DCF — OROVILLE HOSPITAL
Enterprise Value: $-673.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-673.5M
Enterprise Value
$-210.9M
PV of Cash Flows
$-462.5M
PV of Terminal Value
$-744.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $358.3M | $-43.1M | -12.0% | $-58.3M | $-53.0M |
| Year 2 | $369.0M | $-40.7M | -11.0% | $-56.3M | $-46.6M |
| Year 3 | $380.1M | $-38.1M | -10.0% | $-54.2M | $-40.7M |
| Year 4 | $391.5M | $-37.3M | -10.0% | $-53.9M | $-36.8M |
| Year 5 | $403.2M | $-37.4M | -9.0% | $-54.5M | $-33.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-673.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$347.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1253408947320138
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5